about
Detection of BRAF gene mutation in primary choroidal melanoma tissueMenkes protein localization in rat parotid acinar cellsNectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma.Quantifying immunogold labelling in transmission electron microscopy.State of the art in antigen retrieval for immunohistochemistry.The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.S100A7: A rAMPing up AMP molecule in psoriasis.Obesity, Type 1 Diabetes, and Psoriasis: An Autoimmune Triple Flip.Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients.Prolactin increases HO-1 expression and induces VEGF production in human macrophages.Modulation of chitotriosidase during macrophage differentiation.FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population.Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland.Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.Biological therapy induces expression changes in Notch pathway in psoriasis.FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.Immunolocalization of E-cadherin and alphaE-catenin in rat parotid acinar cell under chronic stimulation of isoproterenolAnalysis of matrix metalloproteinase-9 gene polymorphism -1562 C/T in patients suffering from systemic sclerosis with and without ulcersLiver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infectionEffects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skinS100A7/Ran-binding protein 9 coevolution in mammalsS100A7 in Psoriasis: Immunodetection and Activation by CRISPR technologyS100A7, Jab1, and p27kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line
P50
Q28291609-7D547BEC-EBD7-446C-A405-A24438A682FFQ28569754-EF647A83-C738-41D3-9D66-A8BFC7C928ADQ36339260-55B801BE-C18E-44AC-BCB6-A01454BFE1EEQ37127784-F53014AA-5930-4E03-9FD1-A2BBECC1EDB7Q37343615-261DCA18-FEA5-42C6-9424-4B4886A5CA2DQ38152687-7087D5B1-B872-4DD3-8293-924CDB04BE43Q38731589-4C0D1440-D84A-461E-AFAE-975978ABF06AQ38957711-05C53DB2-3FB4-4B2F-AB1F-55A4F96BF148Q39153182-D37B04AC-BDF7-4806-AD1A-B3819E218D72Q40050618-E6904DA8-FB88-4814-BF60-F451C77BD8BFQ45047858-6D0CBDEE-52DC-402D-AD8D-553B70D5E2F0Q46368288-1B286512-9362-46AF-8C28-A1BDC5D24495Q47610403-0A753BF5-9FDA-4B7E-B81C-B63087BC2544Q51313384-C004C0E5-5642-434B-830F-2E2113504512Q51731452-134041EF-B1DC-4C2D-AF7E-F86FD69D970CQ53368019-5E5A1A9A-3984-4F0E-9FB4-F0D2C3E19DECQ55001270-930024DC-D4C7-4B05-B758-ED0C11EAF879Q79257535-5B15553A-F7E9-48D7-880A-19B5F654A1B2Q83760767-4738AA89-ABA5-4F39-8CFB-5D3E66B2B73FQ84233773-4A974200-14AF-48D9-9FC4-93EAC019BC73Q85906582-FED720F9-662C-4AED-976B-FB1977059AC4Q89642674-F16F68A5-7C5F-4949-A52A-A884F11659D0Q91313247-EDC94ED5-E0EF-4709-81F4-4FD450CB5CE9Q91377113-1F58C801-52AA-42C1-80CD-EFCF9C3CF1E5
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Fabio D'Amico
@ast
Fabio D'Amico
@en
Fabio D'Amico
@es
Fabio D'Amico
@nl
type
label
Fabio D'Amico
@ast
Fabio D'Amico
@en
Fabio D'Amico
@es
Fabio D'Amico
@nl
prefLabel
Fabio D'Amico
@ast
Fabio D'Amico
@en
Fabio D'Amico
@es
Fabio D'Amico
@nl
P1153
7005956124
P21
P31
P496
0000-0002-5551-8291